Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liu

Showing results (221-230 of 361) with videos related to

Pageof 37
Sort By:
Experimental Eye Research|August 3, 2021
Characterization and allogeneic transplantation of a novel transgenic cone-rich donor mouse lineYing V Liu, Derek Teng, Gregory J Konar, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2025
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Journal for Immunotherapy of Cancer|February 18, 2021
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lungElizabeth Dudnik, Samuel Kareff, Mor Moskovitz, et al.
Studies in Health Technology and Informatics|February 19, 2005
Teaching intravenous cannulation to medical students: comparative analysis of two simulators and two traditional educational approachesMark W Bowyer, Elisabeth A Pimentel, Jennifer B Fellows, et al.
Cancers|September 13, 2025
Prognostic Significance and Emerging Predictive Potential of Interleukin-1β Expression in Oncogene-Driven NSCLCMengni Guo, Won Jin Jeon, Bowon Joung, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancerJessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2010
Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methodsLei V Liu, Caleb B Bell, Shaun D Wong, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2024
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responsesLisa M Maier, David E Anderson, Christopher A Severson, et al.
Investigative Ophthalmology & Visual Science|October 13, 2021
Localized Structural and Functional Deficits in a Nonhuman Primate Model of Outer Retinal AtrophyYing V Liu, Gregory Konar, Kanza Aziz, et al.
Pageof 37

Showing results (221-230 of 361) with videos related to

Sort By:
Pageof 37
Experimental Eye Research|August 3, 2021
Characterization and allogeneic transplantation of a novel transgenic cone-rich donor mouse lineYing V Liu, Derek Teng, Gregory J Konar, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2025
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Journal for Immunotherapy of Cancer|February 18, 2021
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lungElizabeth Dudnik, Samuel Kareff, Mor Moskovitz, et al.
Studies in Health Technology and Informatics|February 19, 2005
Teaching intravenous cannulation to medical students: comparative analysis of two simulators and two traditional educational approachesMark W Bowyer, Elisabeth A Pimentel, Jennifer B Fellows, et al.
Cancers|September 13, 2025
Prognostic Significance and Emerging Predictive Potential of Interleukin-1β Expression in Oncogene-Driven NSCLCMengni Guo, Won Jin Jeon, Bowon Joung, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancerJessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 2010
Definition of the intermediates and mechanism of the anticancer drug bleomycin using nuclear resonance vibrational spectroscopy and related methodsLei V Liu, Caleb B Bell, Shaun D Wong, et al.
Lung Cancer (Amsterdam, Netherlands)|November 2, 2024
Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK -positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]Jessica R Bauman, Geoffrey Liu, Isabel Preeshagul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responsesLisa M Maier, David E Anderson, Christopher A Severson, et al.
Investigative Ophthalmology & Visual Science|October 13, 2021
Localized Structural and Functional Deficits in a Nonhuman Primate Model of Outer Retinal AtrophyYing V Liu, Gregory Konar, Kanza Aziz, et al.
Pageof 37